1. Home
  2. LEN vs DGX Comparison

LEN vs DGX Comparison

Compare LEN & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lennar Corporation

LEN

Lennar Corporation

HOLD

Current Price

$90.93

Market Cap

22.3B

ML Signal

HOLD

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$203.09

Market Cap

22.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEN
DGX
Founded
1954
1967
Country
United States
United States
Employees
12532
N/A
Industry
Homebuilding
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.3B
22.6B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
LEN
DGX
Price
$90.93
$203.09
Analyst Decision
Sell
Buy
Analyst Count
15
13
Target Price
$97.23
$214.38
AVG Volume (30 Days)
2.4M
653.1K
Earning Date
06-15-2026
04-21-2026
Dividend Yield
2.25%
1.82%
EPS Growth
N/A
13.78
EPS
N/A
2.24
Revenue
N/A
$11,035,000,000.00
Revenue This Year
N/A
$7.53
Revenue Next Year
$4.41
$3.77
P/E Ratio
$15.20
$90.89
Revenue Growth
N/A
11.78
52 Week Low
$81.18
$164.65
52 Week High
$144.24
$213.50

Technical Indicators

Market Signals
Indicator
LEN
DGX
Relative Strength Index (RSI) 52.16 62.81
Support Level $90.21 $200.94
Resistance Level $92.58 $205.00
Average True Range (ATR) 2.77 4.21
MACD 0.45 1.20
Stochastic Oscillator 38.67 74.31

Price Performance

Historical Comparison
LEN
DGX

About LEN Lennar Corporation

Lennar is the second-largest public homebuilder in the United States, behind D.R. Horton, operating in 26 states. The company's homebuilding operations target first-time, move-up, and active adult homebuyers mainly under the Lennar brand name. Lennar's financial-services segment provides mortgage financing and related services to its homebuyers. Miami-based Lennar is also involved in multifamily construction and has invested in numerous housing-related technology startups.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: